TrialPloS one2014
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment.
Antonio Marchetti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
92 papers cite itlatest 60 shown
this paperpooled ittrialcites it